The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study

Background: Using diffusion tensor imaging (DTI), it was previously found that demyelinated gray matter (GM) lesions have increased fractional anisotropy (FA) when compared to normal-appearing gray matter (NAGM) in multiple sclerosis (MS). The biological substrate underlying this FA change is so far unclear; both neurodegenerative changes and microglial activation have been proposed as causal contributors. Objective: To test the proposed hypothesis that microglia activation is responsible for increased FA in cortical GM lesions. Methods: We investigated post-mortem cortical DTI changes in hemispheric, coronally cut sections and investigated the underlying histopathology using immunohistochemistry. Results: Overall, there were few activated microglia/macrophages, and no difference between GM lesions and NAGM was observed. However, cell density was increased in GM lesions compared to NAGM (309.67 ± standard deviation (SD) 124.44 vs 249.95 ± SD 56.75, p = 0.002). Conclusion: FA increase was not due to lesional and non-lesional differences in microglia activation and/or proliferation. We found an increase in general cellular density without a notable difference in cellular size, that is, tissue compaction, as a possible alternative explanation.

[1]  H. D. de Vries,et al.  The Blood-Brain Barrier in Cortical Multiple Sclerosis Lesions , 2007, Journal of neuropathology and experimental neurology.

[2]  F. Barkhof,et al.  Postmortem verification of MS cortical lesion detection with 3D DIR , 2012, Neurology.

[3]  F. Barkhof,et al.  Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis , 2011, Multiple sclerosis.

[4]  B D Trapp,et al.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration , 2003, Multiple sclerosis.

[5]  J. Geurts,et al.  Heterogeneity of cortical lesions in multiple sclerosis , 2012, Neurology.

[6]  M. Horsfield,et al.  Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis , 2013, Multiple sclerosis.

[7]  Tipu Z. Aziz,et al.  Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner , 2011, NeuroImage.

[8]  B. Trapp,et al.  Cortical remyelination: A new target for repair therapies in multiple sclerosis , 2012, Annals of neurology.

[9]  Y. G. Graaf,et al.  What drives MRI-measured cortical atrophy in multiple sclerosis? , 2015, Multiple sclerosis.

[10]  L. Bö,et al.  The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions , 2005, Journal of neuropathology and experimental neurology.

[11]  P. Matthews,et al.  Increased PK11195 PET binding in the cortex of patients with MS correlates with disability , 2012, Neurology.

[12]  Ponnada A Narayana,et al.  Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis , 2011, Multiple sclerosis.

[13]  F. Barkhof,et al.  Accumulation of cortical lesions in MS: relation with cognitive impairment , 2009, Multiple sclerosis.

[14]  P. Voorn,et al.  Neuronal and Axonal Loss in Normal-Appearing Gray Matter and Subpial Lesions in Multiple Sclerosis , 2015, Journal of neuropathology and experimental neurology.

[15]  Kuhlmann,et al.  Identification of glial cell proliferation in early multiple sclerosis lesions , 1998, Neuropathology and applied neurobiology.

[16]  A. Chédotal,et al.  Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells , 2009, Annals of neurology.

[17]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[18]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[19]  C. Wegner,et al.  Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination , 2014, Acta Neuropathologica.

[20]  M. Inglese,et al.  Ultra-High-Field MRI Visualization of Cortical Multiple Sclerosis Lesions with T2 and T2*: A Postmortem MRI and Histopathology Study , 2015, American Journal of Neuroradiology.

[21]  R I Grossman,et al.  Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis , 2015, Multiple sclerosis.

[22]  Alessandra Bertoldo,et al.  Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. , 2011, Radiology.

[23]  Khader M Hasan,et al.  Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: initial findings. , 2008, Radiology.